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Conclusions: These findings identify fibrillarin and GAR1 as novel
interactors of SMN and suggest a function for the SMN complex in the
assembly and metabolism of snoRNPs. We propose that the SMN complex
performs functions necessary for the biogenesis and function of diverse
ribonucleoprotein complexes.
Background is tightly associated with Gemin2 (formerly SIP1), the
DEAD box RNA helicase Gemin3, and Gemin4 in a largeSpinal muscular atrophy (SMA) is an autosomal recessive
neurodegenerative disease characterized by progressive multiprotein complex [11–13]. In the cytoplasm, the SMN
complex functions in the assembly of spliceosomalloss of motor neurons in the anterior horn of the spinal
cord, resulting in muscular weakness and atrophy [1]. snRNPs [11, 14–16]. In the nucleus, SMN functions in
transcription and pre-mRNA splicing [15, 17, 18], possiblyThe survival of motor neurons gene (SMN) is the SMA-
determining gene [2]. In humans, the SMN gene is dupli- in the assembly and regeneration of components of the
RNA polymerase II transcription-processing machinery.cated as an inverted repeat on chromosome 5, and only
deletions or mutations in the telomeric copy, SMN1, result SMN forms large oligomers, and this appears to be essen-
tial for its activity, since a defect in SMN oligomerizationin SMA [3]. The centromeric copy, SMN2, does not pro-
tect from SMA because, as a result of a single nucleotide correlates with SMA [19, 20]. SMN oligomerization is
necessary for efficient interaction with the arginine- anddifference from SMN1, it mostly produces an alternatively
spliced SMN mRNA lacking the sequences encoded by glycine-rich carboxyl termini of SmB, SmD1, and SmD3,
while SMA-causing SMNmutants found in SMA patientsexon 7 [2, 4]. The amount of full-length SMN produced
by SMN2 is sufficient to overcome lethality in most cells, are deficient in both splicing regeneration and the interac-
tion with Sm proteins and Gemin3 [12, 15, 16, 20, 21].but not in motor neurons in which the amount of SMN
inversely correlates with the severity of the disease [5–9].
Preribosomal RNA (rRNA) transcription and processing
and the assembly of ribosomes take place in the nucleolus,The SMN protein is found both in the cytoplasm and in
the nucleus where it is concentrated in gems, which are where rRNAs are transcribed, cleaved into the 28S, 18S,
and 5.8S rRNA molecules, and further modified by basenuclear bodies similar in size and number to Cajal (coiled)
bodies (CBs) and often associated with them [10]. SMN methylation and pseudouridylation. These processes are
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mediated by small nucleolar ribonucleoprotein particles interactions with SMN described above, we performed
in vitro binding experiments using purified recombinant(snoRNPs), which are conserved throughout evolution
his-tagged SMN. Figure 1c shows that SMN, detectedfrom yeast to humans [22–24]. SnoRNPs can be divided
byWestern blotting using an anti-T7 tag monoclonal anti-into two classes, the box C/D class and the box H/ACA
body, interacts directly and efficiently with both fibrillarinclass, based on the presence of conserved RNA sequence
and GAR1.motifs and on different protein compositions [25]. Box
C/D snoRNPs are necessary for cleavage and site-specific
The interaction of SMN with fibrillarin and GAR1 requiresmethylation of rRNA [26–29]. Box H/ACA snoRNPs
the conserved Y/G box and is defective in SMN mutantsguide the pseudouridylation of rRNA [30–32]. The speci-
found in some SMA patientsficity of the site of modification is established by short
SMNcontains two evolutionarily conserved regions (blackregions of complementarity between each snoRNA and
boxes in Figure 2a): the one close to the amino terminusthe rRNA. To understand the biogenesis of these RNPs,
is involved in SMN binding to Gemin2, and the one close
much work has been focused on the identification of to the carboxyl terminus is involved in SMN binding to
snoRNP-specific proteins [33]. Fibrillarin, a common au- itself, Sm proteins, and Gemin3 [11, 12, 19, 20]. We ana-
toantigen of human autoimmune diseases, is a specific lyzed the deletion mutants of SMN indicated in Figure
component and amarker of boxC/D snoRNPs [34]. GAR1 2a for their capacity to interact in vitro with fibrillarin and
is a specific component and a marker of box H/ACA GAR1. Figure 2b shows that a deletion of the Y/G box
snoRNPs [35, 36]. Interestingly, mammalian telomerase abolishes SMN interaction with fibrillarin and GAR1.
RNP is also a member of the H/ACA snoRNPs, although Conversely, the dominant-negative mutant SMNN27
it is apparently not involved in rRNA metabolism [36]. binds as well as wild-type SMN. The SMN2 gene mostly
produces a truncated version of SMN lacking the amino
Here, we investigated the possible relationship between acids encoded by exon 7 (see Background). In addition,
the SMN complex and snoRNP metabolism suggested some SMA patients carry point mutations that cluster in
by the earlier identification of an interaction between the Y/G box, the most common of which is the Y272C
SMN and fibrillarin in the yeast two-hybrid system [10] mutation [2, 41]. Figure 2c shows that the binding of
and the observation of a nucleolar localization of Gemin4 SMN to both fibrillarin and GAR1 is strongly impaired
[13]. We show that fibrillarin and GAR1 are novel direct by either the Y272C point mutation or the SMNEx7
targets of SMN interaction both in vitro and in vivo. Our deletion. These results demonstrate that the conserved
findings provide evidence for a link between the SMN Y/G box is necessary for SMN interaction with fibrillarin
complex and snoRNP metabolism and further extend the and GAR1. Moreover, SMN mutations found in SMA
range of possible cellular defects associated with SMA. patients severely impair the interaction with these
snoRNP-specific proteins.
Results
SMN interacts directly with the snoRNP proteins The arginine- and glycine-rich domains of fibrillarin
fibrillarin and GAR1 and GAR1 are necessary for SMN interaction
We first examined the capacity of the known components Fibrillarin and GAR1 contain arginine- and glycine-rich
of the SMN complex to interact with the snoRNP-specific domains, also known as RGG boxes and GAR domains
proteins fibrillarin and GAR1. SMN, Gemin2, Gemin3, (Figure 3a,c). To determine the domains of fibrillarin and
and Gemin4 were translated in vitro in the presence of GAR1 that are involved in SMN interaction, we generated
[35S]methionine and incubated with purified recombinant a series of deletion mutants of fibrillarin and GAR1. A
fibrillarin fused to GST, GAR1 fused to GST, or GST schematic representation of the fibrillarin domain struc-
alone as a control. Figure 1a shows that, of these proteins, ture and the positions of the amino- and carboxyl-terminal
only SMN binds efficiently to both fibrillarin and GAR1, deletions are shown in Figure 3a. Wild-type fibrillarin and
but not to GST. Fibrillarin and GAR1 bind RNA in vitro the indicated deletion mutants were translated in vitro in
[37, 38]. It was important to exclude the possibility that the presence of [35S]methionine and tested for their ability
these interactions with SMN were nonspecifically medi- to bind purified recombinant SMN fused to GST. Figure
ated by RNAs present in the translation system because 3b shows that wild-type fibrillarin and a deletion of the
SMN can also bind to nucleic acids [39, 40]. To do so, in first 23 amino acids (N23) bind efficiently to SMN. In
vitro-translated [35S]methionine SMN was treated with contrast, the deletion of the RGG domain (N79) and all
RNase A before being added to the binding reaction. additional amino-terminal deletions abolish binding to
RNase A treatment had no effect on SMN interaction SMN. Therefore, the RGG domain of fibrillarin is neces-
with both fibrillarin andGAR1 (Figure 1b). As a reference, sary for its interaction with SMN. However, the RGG
the weak SMN interaction with hnRNPA1 is abolished domain of fibrillarin is not sufficient for SMN interaction.
by RNase treatment, indicating that this interaction is The RGG domain fused to GST does not bind SMN
bridged by RNAs. To rule out the possibility that some (data not shown), and only the carboxyl-terminal  helix
domain of fibrillarin appears to be dispensable for thecomponents in the rabbit reticulocyte lysate mediate the
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Figure 1
SMN interacts directly with fibrillarin and
GAR1 in vitro. (a) In vitro-translated
[35S]methionine SMN, Gemin2, Gemin3, or
Gemin4 were incubated with either GST,
GST-fibrillarin (GST-Fb), or GST-GAR1 as
indicated. Bound proteins were analyzed by
SDS-PAGE and autoradiography. Ten percent
of the input is shown. (b) In vitro-translated
[35S]methionine SMN, previously treated or
untreated with RNaseA as indicated, was
incubated with GST-fibrillarin (Fb), GST-
GAR1 (GAR1), GST-hnRNPA1 (A1), or
GST. Bound proteins were analyzed by SDS-
PAGE and autoradiography. Ten percent of
the input is shown. (c) Purified recombinant
his-tagged SMN was incubated with GST-
fibrillarin, GST-GAR1, or GST. Bound SMN
was detected by Western blotting using anti-
T7 tag antibodies. Five percent of the input is
shown.
interaction, as longer carboxyl-terminal deletions abolish with several antibodies. As shown in Figure 4, myc-tagged
fibrillarin and GAR1 were expressed and could be specifi-SMN binding (C53, Figure 3b).
cally immunoprecipitated with anti-myc antibodies. All
GAR1 contains a conserved domain in the middle of the the known components of the SMN complex, namely
protein flanked by amino- and carboxyl-terminal arginine- SMN, Gemin2, Gemin3, and Gemin4, but not the abun-
and glycine-rich domains (Figure 3c). We generated two dant nuclear RNA binding protein hnRNPA1, were coim-
deletion mutants of GAR1 lacking either the amino- or munoprecipitated with both fibrillarin and GAR1. None
the carboxyl-terminal RGG domains. Wild-type GAR1 of these proteins were detected in the control immunopre-
and deletion mutants were translated in vitro in the pres- cipitate from mock-transfected extracts. Consistent with
ence of both [35S]methionine and [35S]cysteine and tested the in vitro binding experiments described above, these
for their ability to bind purified recombinant SMN fused findings indicate that a subset of SMN complexes is asso-
to GST. Figure 3d shows that wild-type GAR1 binds to ciated with fibrillarin and GAR1 in vivo. It appears that
GST-SMN, but not to GST. Conversely, the deletion of a higher proportion of Gemin4 compared to the other
either RGG domain abolished the interaction with SMN, components of the SMN complex is immunoprecipitated
indicating that they are both necessary for SMN inter- with both fibrillarin and GAR1. Together with its unique
action. nucleolar localization [13], this observation suggests that
Gemin4 may be associated with snoRNPs also in the
Association of the SMN complex with fibrillarin absence of the other components of the SMN complex.
and GAR1 in vivo This possibility is currently being investigated further.
We further examined the association between snoRNPs
and the SMN complex in vivo by immunoprecipitation Transcription-dependent association of SMN with
fibrillarin, GAR1, and the nucleolusexperiments. To do so, we transiently transfected into
293T cells DNA constructs for the expression of myc- In the nucleus, SMN is particularly highly concentrated
in gems [10]. Gems contain the components of the SMNtagged fibrillarin (mycFb), GAR1 (mycGAR1), or the vec-
tor alone as a control (mock). Nucleoplasmic extracts were complex, but not the CB marker coilin [10–13]. The fact
that gems and CBs each contain distinct components indi-prepared from transfected cells and subjected to immuno-
precipitation using anti-myc antibodies. Immunoprecipi- cate that they are distinct and independent nuclear struc-
tures, although there is a dynamic functional relationshiptated proteins and an aliquot of the respective extracts
were analyzed by SDS-PAGE and by Western blotting between them and they are more often found colocalized
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Figure 2 Figure 3
The mapping of SMN domains required for interaction with fibrillarin
and GAR1. (a) A schematic representation of SMN protein structure.
The position of the amino acids corresponding to each exon/exon
boundary and the SMN deletion mutants are indicated. Black boxes
indicate evolutionarily conserved SMN domains. (b) In vitro-translated
[35S]methionine SMN wt or the indicated deletion mutants were
incubated with GST-fibrillarin, GST-GAR1, or GST. Bound proteins
were analyzed by SDS-PAGE and autoradiography. Ten percent of
the input is shown. (c) SMN mutants found in SMA patients are
defective in binding to snoRNP proteins. In vitro-translated
[35S]methionine SMN wt, the point mutant Y272C, or the deletion
Ex7 were incubated with GST-fibrillarin, GST-GAR1, or GST.
Bound proteins were analyzed by SDS-PAGE and autoradiography.
Ten percent of the input is shown.
[10, 15, 42, 43].We studied by indirect immunofluores-
The RGG domains of fibrillarin and GAR1 are necessary for thecence microscopy the localization of fibrillarin and GAR1
interaction with SMN. (a) A schematic representation of the fibrillarin
relative to SMN in untreated HeLa cells or in cells treated protein structure [60]. The RGG box, the RNA binding domain (RBD),
with actinomycin D at a concentration (0.04 g/ml) that and the  helix are indicated. The positions of the fibrillarin deletion
mutants used are indicated. (b) In vitro-translated [35S]methionineinhibits transcription by RNA polymerase I, but not RNA
fibrillarin or the indicated deletion mutants were incubated with GST-polymerase II. Figures 5a–c and 6a–c show that SMN,
SMN. Bound proteins were analyzed by SDS-PAGE and
fibrillarin, and GAR1 colocalize in gems/CBs, but not in autoradiography. Ten percent of the input is shown. (c) A schematic
the nucleolus, where SMN is not detectable under normal representation of GAR1 protein structure [44]. The RGG boxes, the
central core domain, and the position of the GAR1 deletion mutantsconditions. After actinomycin D treatment, fibrillarin and
used are indicated. (d) In vitro-translated [35S]methionine andGAR1, and very likely snoRNPs, display an overall identi-
[35S]cysteine GAR1 or the indicated deletion mutants were incubated
cal pattern of reorganization (Figures 5 and 6). After 1.5 with GST-SMN or GST. Bound proteins were analyzed by SDS/PAGE
hr of actinomycin D treatment, fibrillarin and GAR1 accu- and autoradiography. Ten percent of the input is shown.
mulate at the nucleolar periphery. In addition, their nu-
cleoplasmic pool increases, and their colocalization with
SMN in gems is barely detectable (Figures 5d–f and 6d–f,
ery of nucleoli (arrowheads in Figures 5f and 6f). SMNarrows in 5e and 6e). Gems are more resistant than CBs
association with nucleoli is transient because after longerto inhibition of RNA polymerase I transcription, as CBs
actinomycinD treatment (3 hr), SMN is no longer concen-are disrupted under these conditions and the CB marker
trated at the periphery of nucleoli, displaying a morep80 coilin localizes at the nucleolar periphery (data not
diffuse and weaker nucleolar localization in addition toshown). Interestingly, in approximately 10%–20% of the
strong labeling of gems (Figures 5g–i and 6g–i). At thiscells, some of the SMN, in addition to its presence in
gems, colocalizes with fibrillarin and GAR1 at the periph- time point, no residual fibrillarin or GAR1 staining is
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Figure 4 tein in large structures (Figure 7d–f). Often, these struc-
tures are found at the periphery of nucleoli (Figure 7g),
and sometimes higher local concentrations of fibrillarin
are observed at the interface, or the connecting region,
between the two structures (Figure 7f). It was then impor-
tant to determine whether fibrillarin alone or the entire
snoRNP accumulated in these structures. To do so, we
carried out in situ hybridization to localize U3 snoRNA,
the most abundant member of box C/D snoRNPs. Figure
7g–i shows that U3 snoRNA, like fibrillarin, also accumu-
lates outside of the nucleoli in the SMNN27-containing
structures.
We also tested the effect of SMNN27 expression on
the localization of GAR1. Consistent with its reported
localization in untransfected cells [44], in cells transfected
with SMNwt, GAR1 is localized to the nucleolus and CBs
(Figure 7j–l). Figure 7m–o shows that GAR1 is also chased
out of the nucleolus and accumulates in the SMNN27-
containing structures. As observed for fibrillarin, higher
local concentrations of GAR1 are observed at the interface
between the two structures (Figure 7n).
The association of the SMN complex with fibrillarin and GAR1 in vivo. Discussion
293T cells were transiently transfected with DNA constructs We demonstrated here that SMN binds directly to fibril-
expressing myc-tagged fibrillarin (myc-Fb), myc-tagged GAR1 (myc-
larin and GAR1, constituents of box C/D and box H/ACAGAR1), or with vector alone (mock). Immunoprecipitation (IP)
snoRNPs, respectively. An interaction between SMN andexperiments were carried out from nucleoplasmic extracts using anti-
myc antibodies. Immunoprecipitates were analyzed by SDS-PAGE fibrillarin was initially observed in yeast two-hybrid
and Western blotting with the antibodies to the indicated proteins. screening [10]. We showed that SMN binds directly to
Five percent of the input is shown.
fibrillarin and GAR1 in vitro and that the evolutionarily
conserved Y/G box, near the carboxyl terminus of SMN,
is required for these interactions. Moreover, both SMN
detected within gems. After 4.5 hr of actinomycin D treat- Y272C, the most common point mutant found in non-
ment, the weak nucleolar staining of SMN is no longer SMN1-deleted SMA patients, and SMNEx7, the main
detectable (Figures 5j–l and 6j–l). These results indicate product of the SMN2 gene (that lacks the amino acids
that the association of SMN with snoRNPs in vivo is encoded by exon 7), are strongly defective in these inter-
dynamic and related to RNA polymerase I transcription. actions. These results suggest that a defect in the associa-
tion of SMN with snoRNP proteins likely contributes to
Expression of SMNN27 causes accumulation the pathogenesis of SMA.
of snoRNPs outside the nucleolus
To further address the involvement of the SMN complex
We also found that the arginine- and glycine-rich (RG)in snoRNP metabolism, we examined the subcellular lo-
domains of both fibrillarin and GAR1 are necessary, butcalization of fibrillarin and GAR1 in cells expressing
not sufficient, for the interaction of these proteins withSMNN27. Transfection in HeLa cells of this dominant-
SMN. These results strengthen the emerging view thatnegative mutant of SMN blocks snRNP assembly in the
SMN binds RG-rich domains. Several SMN-interactingcytoplasm and causes a selective accumulation of several
partners such as SmB, SmD1, SmD3, LSm4, and RNAcomponents of the RNA polymerase II transcription/pro-
helicase A contain RG-rich regions that are necessary forcessing machinery in large nuclear structures that also
SMN interaction [18, 21]. In the case of SmD1, SmD3,contain the known components of gems and CBs [15, 18].
and LSm4, RG-rich domains are both necessary and suffi-Concomitantly, SMNN27 inhibits mRNA and rRNA
cient for their interaction with SMN [21]. It is likely thattranscription. Similar to untransfected cells, fibrillarin is
SMN binds directly to the RG-rich regions of fibrillarinlocalized in the nucleolus and CBs of cells transfected
and GAR1, but either additional determinants in the con-with SMNwt (Figure 7a–c). Gems that are completely
text of the full-length proteins or the specific presentationseparate from CBs are indicated by the arrows in Figure
of these domains is also critical and contributes to the7c. Strikingly, in cells transfected with SMNN27, fibril-
larin is relocalized and accumulates with the mutant pro- avidity or specificity of the interaction. For example,
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Figure 5
The dynamic association of SMN with fibrillarin
in vivo. (a–l) Double-label confocal indirect
immunofluorescence detection of SMN
(a,d,g,j) and fibrillarin (b,e,h,k) in HeLa cells
either untreated as a control (a–c) or treated
with 0.04 g/ml actinomycin D for 1.5 hr
(d–f), 3 hr (g–i), and 4.5 hr (j–l). The respective
combined images are shown in (c), (f), (i),
and (l). Colocalization results in a yellow signal.
Dashed lines demarcate the nucleus. The
arrows in (e) indicate residual colocalization
of fibrillarin and SMN in gems. The large
arrowhead in (f) points to SMN colocalized
with fibrillarin in the nucleolus. The scale bars
represent 5 m.
hnRNPA1 contains an RGG box, but it does not bind low doses of actinomycin D, suggesting that it is depen-
dent on RNA polymerase I transcription. Under the sameSMN (see Figure 1b).
treatments, a subset of SMN transiently associates with
nucleoli. It is possible that the SMN complex associatesThe interaction of SMN with snoRNP proteins was fur-
ther investigated in vivo. Coimmunoprecipitation experi- with the nucleoli under normal conditions, but its associa-
tion is too transient to be detectable and only becomesments demonstrated that the SMNcomplex interacts with
fibrillarin and GAR1 in vivo (see Figure 4). However, apparent at early times after the inhibition of RNA poly-
merase I transcription. The reorganization of snoRNPsfibrillarin and GAR1 are not intrinsic components of the
SMN complex and, similar to Sm and Lsm proteins and upon expression of SMNN27 also points to a functional
interaction between snoRNPs and the SMN complex inRNA helicase A [10, 18, 20, 21], we consider fibrillarin
andGAR1 to be potential substrates of the SMNcomplex. vivo. We observed that snoRNPs are depleted from the
nucleolus and accumulate in the SMNN27-containingSeveral pieces of evidence indicate a dynamic association
between the SMN complex and snoRNPs in vivo. Fibril- structures in cells expressing this dominant-negative mu-
tant of SMN. In these cells, transcription is inhibited inlarin and GAR1 (and CBs) colocalize with SMN (and
gems), but this colocalization is lost upon treatment with both the nucleoplasm and the nucleolus [18], and the
Research Paper SMN interaction with fibrillarin and GAR1 Pellizzoni et al. 1085
Figure 6
The dynamic association of SMN with GAR1
in vivo. (a–l) Double-label confocal indirect
immunofluorescence detection of SMN
(a,d,g,j) and GAR1 (b,e,h,k) in HeLa cells
either untreated as a control (a–c) or treated
with 0.04 g/ml actinomycin D for 1.5 hr
(d–f), 3 hr (g–i), and 4.5 hr (j–l). The respective
combined images are shown in (c), (f), (i),
and (l). Colocalization results in a yellow signal.
Dashed lines demarcate the nucleus. The
arrows in (e) indicate residual colocalization
of GAR1 and SMN in gems. The large
arrowheads in (f) point to SMN colocalized
with GAR1 in the nucleolus. The scale bars
represent 5 m.
reorganization of snoRNPs may contribute to the inhibi- vertebrate snoRNAs of both classes do not contain a TMG
cap, as they are excised by exonucleolytic processing fromtion of nucleolar transcription. Similarly, the expression
of dominant-negative mutants of p80 coilin and Nopp140 the introns of host genes coding for components of the
translational machinery [51]. Specific proteins are thoughthave been shown to cause the reorganization of snoRNPs
as well as inhibit transcription in the nucleolus [45, 46]. to bind snoRNAs early in the snoRNP assembly pathway
and contribute to their stability by protecting their ex-These findings pointed to a functional link between the
nucleolus and CBs [47, 48], and our results suggest a tremities from exonucleolytic digestion. It has been sug-
gested that snoRNP protein assembly takes place simulta-functional link between the SMN complex and the func-
tion or metabolism of snoRNPs. neously, or shortly after, transcription/processing of the
pre-mRNAs from which they are derived, and then they
localize to the nucleolus [52]. In addition to the nucleolus,SnoRNAs are produced and assembled in the nucleus
[47–49]. Some snoRNAs such as U3, the most abundant snoRNPs localize in CBs, but the functional relevance of
their presence in CBs is not known. It seems plausibleand well-characterized snoRNA, are transcribed by RNA
polymerase II in the nucleoplasm and have a trymethylgu- that snoRNPs, as part of their biogenesis pathway, associ-
ate with the SMN complex and, similar to the pathwayanosine (TMG) cap structure at the 5-end [50]. Most
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Figure 7 related macromolecules that form within the nucleus, be-
cause reciprocal interactions slow down their diffusion
rates in the nucleoplasm [48]. Therefore, although high
local concentrations of the components that function in
this pathway (i.e., SMN complex and snoRNPs) can be
observed as discrete structures at the light microscope
level, their association and activities need not necessarily
take place in these structures.
By analogy with the role of SMN in spliceosomal snRNP
assembly [14–16], the interaction of SMN with fibrillarin
and GAR1 likely reflects a function of the SMN complex
in the biogenesis and assembly of snoRNPs. Moreover,
this association may not only be limited to the initial
assembly of new snoRNPs: because mature snoRNPs also
appear to move continuously between nucleolus, nucleo-
plasm, and CBs [54, 55], this may reflect the need for a
functional regeneration or recycling of snoRNPs akin to
the one we have proposed for snRNPs after splicing [15].
We envision that this aspect of snoRNP metabolism also
requires the functions of the SMN complex and is thus
blocked by SMNN27.
Conclusions
We showed that fibrillarin and GAR1, constituents of box
C/D and boxH/ACA snoRNPs, respectively, bind directly
to SMN, but not to SMN mutants found in some SMA
patients. These findings further extend the range of tar-
gets of SMN interaction and indicate additional defects
that may be associated with SMA. They also suggest a
role for the SMN complex in snoRNP biogenesis and
function. The observation that fibrillarin and GAR1 con-
tain RGG domains that are required for SMN interaction
strengthens the view that SMN binds arginine- and gly-
cine-rich domains and suggests that these domains are a
common feature necessary for substrate recognition by the
The expression of SMNN27 causes fibrillarin, U3 snoRNA, and GAR1 SMN complex. The reorganization of snoRNPs in cells
to accumulate outside the nucleolus. (a–f) Double-label confocal expressing the dominant-negative mutant SMNN27
immunofluorescence experiments using anti-myc (a,d) and anti- points to a functional interaction of the SMN complexfibrillarin (b,e) antibodies on HeLa cells transiently transfected with
with snoRNPs in vivo. We propose that the functions ofmycSMNwt (a–c) and mycSMNN27 (d–f). (g–i) Double-label
confocal immunofluorescence experiments using anti-myc (g) and the SMN complex are not limited to the metabolism
an oligonucleotide probe complementary to U3 (h) to detect U3 of spliceosomal snRNPs, but extend to snoRNPs and
snoRNA by in situ hybridization of an HeLa cell transiently transfected possibly additional RNPs, such as telomerase. We suggestwith mycSMNN27. (j–o) Double-label confocal immunofluorescence
that the SMNcomplex is a general macromolecular assem-experiments using anti-myc (j,m) and anti-GAR1 (k,n) antibodies on
HeLa cells transiently transfected with mycSMNwt (j–l) and bly machine for the biogenesis and functional mainte-
mycSMNN27 (m–o). Gems are indicated by arrows in (c) and (l). nance of diverse RNPs.
The differential interference contrast (DIC) image and anti-myc staining
are shown combined in (g). Nucleoli are indicated by arrows in (i).
The respective combined images are shown in (c), (f), (i), (l), and (o). Materials and methods
Colocalization results in a yellow signal. Dashed lines demarcate DNA constructs
the nucleus. The scale bars represent 5 m. The cDNAs encoding SMN, Gemin2, Gemin3, and Gemin4 were pre-
viously described [10–13]. Plasmids for expressing myc-tagged SMN
wild-type and mutant proteins were previously described [15, 20]. The
fibrillarin cDNA open reading frame (ORF) was previously isolated in a
two-hybrid screening [10]. The GAR1 cDNA ORF was amplified by RT-recently proposed for the maturation of spliceosomal
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